Inventor · disambiguated record
Jeanette Marjorie Wood
Also filed as: WOOD JEANETTE · WOOD JEANETTE M · WOOD JEANETTE MARJORIE
19 granted patents·18 pending applications·604 citations·filing 1985–2016
96Inventor score
Top patents by PatentIndex Score
37 records- 0196US6258812B1Phthalazines with angiogenesis inhibiting activityNOVARTIS AG·Filed 1998·Granted Jul 10, 2001·206 cites·30 claims
- 0295US6448277B2VEGF receptor tyrosine kinase inhibitorsNOVARTIS AG·Filed 2001·Granted Sep 10, 2002·64 cites·19 claims
- 0394US6878720B2VEGF receptor tyrosine kinase inhibitorsNOVARTIS AG·Filed 2002·Granted Apr 12, 2005·50 cites·16 claims
- 0490US4780401ANovel monoclonal antibodies to human renin and hybridoma cells, processes for their preparation and their applicationsCIBA GEIGY CORP·Filed 1985·Granted Oct 25, 1988·71 cites·13 claims
- 0589US7002022B2N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGFSCHERING AG·Filed 2004·Granted Feb 21, 2006·24 cites·8 claims
- 0687US6710047B2Phthalazines with angiogenesis inhibiting activityNOVARTIS AG·Filed 2003·Granted Mar 23, 2004·25 cites·4 claims
- 0786US7122547B1Anthranilic acid amides and the use thereof as medicamentsNOVARTIS AG·Filed 1999·Granted Oct 17, 2006·79 cites·14 claims
- 0884US6686347B2Phthalazine derivatives for treating inflammatory diseasesNOVARTIS AG·Filed 2001·Granted Feb 3, 2004·18 cites·30 claims
- 0983US8778962B2Treatment of solid tumors with rapamycin derivativesLANE HEIDI·Filed 2012·Granted Jul 15, 2014·4 cites·6 claims
- 1083US6514974B2Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activityNOVARTIS AG·Filed 2001·Granted Feb 4, 2003·15 cites·8 claims
- 1182US8410131B2Cancer treatmentLANE HEIDI·Filed 2002·Granted Apr 2, 2013·11 cites·9 claims
- 1276US7612052B2Combinations comprising epothilones and pharmaceutical uses thereofNOVARTIS AG·Filed 2008·Granted Nov 3, 2009·2 cites·9 claims
- 1372US7329660B2Phthalazine derivatives for treating inflammatory diseasesNOVARTIS AG·Filed 2006·Granted Feb 12, 2008·1 cites·4 claims
- 1464US8877771B2Treatment of solid tumors with rapamycin derivativesLANE HEIDI·Filed 2013·Granted Nov 4, 2014·0 cites·22 claims
- 1563US6911440B2Phthalazine derivatives for treating inflammatory diseasesNOVARTIS AG·Filed 2003·Granted Jun 28, 2005·1 cites·28 claims
- 1663US2014105895A1Treatment of solid tumors with rapamycin derivativesLANE HEIDI·Filed 2013·Application pending·0 cites
- 1762US8008330B2Combinations comprising epothilones and pharmaceutical uses thereofNOVARTIS AG·Filed 2009·Granted Aug 30, 2011·0 cites·3 claims
- 1861US8436010B2Treatment of solid tumors with rapamycin derivativesLANE HEIDI·Filed 2012·Granted May 7, 2013·0 cites·11 claims
- 1961US2016303092A1Treatment of solid tumors with rapamycin derivativesNOVARTIS PHARMACEUTICALS CORP·Filed 2016·Application pending·0 cites
- 2061US2013244951A1Treatment of solid tumors with rapamycin derivativesLANE HEIDI·Filed 2013·Application pending·0 cites
- 2161US2013253000A1Treatment of solid tumors with rapamycin derivativesLANE HEIDI·Filed 2013·Application pending·0 cites
- 2259US6271233B1Method for treating ocular neovascular diseasesNOVARTIS AG·Filed 1999·Granted Aug 7, 2001·21 cites·13 claims
- 2359US2010098691A1Combination of benzimidazole anti-cancer agent and a second anti-cancer agentS BIO PTE LTD·Filed 2008·Application pending·0 cites
- 2459US2009247638A1Pharmaceutical use of cox-2-inhibitors in angiogenesis-mediated ocular disordersBRAZZELL ROMULUS KIMBRO·Filed 2009·Application pending·0 cites
- 2557US2006074112A1N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitorsALTMANN KARL-HEINZ·Filed 2005·Application pending·0 cites
- 2657US2009196871A1Use of 4-pyridylmethylphthalazines for cancer treatmentDUGAN MARGARET HAN·Filed 2009·Application pending·0 cites
- 2754US2005176711A1Phthalazine derivatives for treating inflammatory diseasesFiled 2005·Application pending·0 cites
- 2851US2006270665A1Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activityWOOD JEANETTE M·Filed 2006·Application pending·0 cites
- 2950US2009209495A1Use of edg receptor binding agents in cancerBAUMRUKER THOMAS·Filed 2009·Application pending·0 cites
- 3049US6214819B1Method for treating ocular neovascular diseasesNOVARTIS AG·Filed 1999·Granted Apr 10, 2001·12 cites·18 claims
- 3149US2005043410A1Pharmaceutical use of cox-2-inhibitors in angiogenesis-mediated ocular disordersFiled 2003·Application pending·0 cites
- 3249US2012322874A1Pharmaceutical UsesBRAZZELL ROMULUS KIMBRO·Filed 2012·Application pending·0 cites
- 3347US2004176327A1Use of bisphosphonic acids for treating angiogenesisFiled 2004·Application pending·0 cites
- 3446US2004258770A1Use of 4-pyridylmethylphthalazines for cancer treatmentFiled 2002·Application pending·0 cites
- 3545US2008085902A1Combination Of A Vegf Receptor Inhibitor Or With A Chemotherapeutic AgentBOLD GUIDO·Filed 2004·Application pending·0 cites
- 3642US2004235796A1Combinations comprising epothilones and pharmaceutical uses thereofFiled 2002·Application pending·0 cites
- 3742US2002142996A1Use of bisphosphonic acids for treating angiogenesisFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeanette Marjorie Wood files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →